( Equity said Fergus would reinforce Ba...)Biotech executive books a career flight that's closer to home

Equity, said Fergus would reinforce Baird's focus on the life-science tools market. He expects Fergus to help Baird's healthcare and life science teams evaluate new investment opportunities, and manage its current portfolio of companies. Baird Private Equity has raised and managed $1.8 billion in capital.

Gregg brings operational experience and perspective that will help us in a number o......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/19/07


Page: 1 2 3
Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Gala Biotech among companies sold for $3.3 billion
3. Biotech with Madison ties raises $21M in capital
4. Biotech firm uses live heart tissue in drug screens
5. Biotech talent drew venture-funded firm to Madison
6. Biotech firm has strokes, Alzheimers in its sights
7. 42 days until the 2006 Olympics of Biotechnology in Chicago
8. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
9. Biotech leads list of top U.S. companies to work for
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says